Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
Background: Hematological malignancies, like other cancers, are on the rise. Their treatments have been revolutionized using biological molecules (biologics and biosimilars). These novel agents are used in the care of cancer patients and have significantly improved survival. While biosimilars are wi...
Saved in:
Main Authors: | Rufai A. Dachi, Mustapha S. Umar, Maryam Mahdi, Nura H. Alkali, Falmata G. Mustapha, Fatima M. Muhammad, Alhaji Abdu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
Series: | International Journal of Medicine and Health Development |
Subjects: | |
Online Access: | https://doi.org/10.4103/ijmh.ijmh_33_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01) -
Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01) -
Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia
by: Antonio Gallardo-Pizarro, et al.
Published: (2024-12-01) -
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults
by: Hao Li, et al.
Published: (2025-01-01) -
Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review
by: Aleksandra Janowiak-Majeranowska, et al.
Published: (2024-07-01)